Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration"

被引：0
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca 400012, Romania
来源：
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 2018年 / 11卷 / 11期
关键词：
POLYPOIDAL CHOROIDAL VASCULOPATHY; AFLIBERCEPT TREATMENT; CLASSIFICATION;
D O I：
10.18240/ijo.2018.11.25
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1884 / 1885
页数：2
相关论文
共 50 条
  • [1] Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
    Dan C?lug?ru
    Mihai C?lug?ru
    International Journal of Ophthalmology, 2018, (11) : 1884 - 1886
  • [2] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Bekir Kü?ük
    Sibel Kaday?f??lar
    Bora Eldem
    International Journal of Ophthalmology, 2018, (04) : 645 - 649
  • [3] Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration" Reply
    Kucuk, Bekir
    Kadayifcilar, Sibel
    Eldem, Bora
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (11) : 1885 - 1886
  • [4] Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
    Kucuk, Bekir
    Kadayifcilar, Sibel
    Eldem, Bora
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (04) : 645 - 649
  • [5] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration
    Matonti, Frederic
    Courjaret, Jean Christophe
    Hoffart, Louis
    Amouyal, Franck
    Denis, Daniele
    OPHTHALMOLOGY, 2013, 120 (09) : E68 - E69
  • [6] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply
    Silva, Rufino
    Axer-Siegel, Ruth
    Eldem, Bora
    Guymer, Robyn
    Kirchhof, Bernd
    Papp, Andras
    Seres, Andras
    Gekkieva, Margarita
    Nieweg, Annette
    Pilz, Stefan
    OPHTHALMOLOGY, 2013, 120 (09) : E69 - E69
  • [7] LONG-TERM EFFICACY OF RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Chew, Jamie
    Syed, Adil
    Joachim, Nichole
    Li, Haitao
    Broadhead, Geoffrey K.
    Zhu, Meidong
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 98 - 98
  • [8] Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
    Muether, Philipp S.
    Hoerster, Robert
    Hermann, Manuel M.
    Kirchhof, Bernd
    Fauser, Sascha
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (02) : 453 - 458
  • [9] Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
    Philipp S. Muether
    Robert Hoerster
    Manuel M. Hermann
    Bernd Kirchhof
    Sascha Fauser
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 453 - 458
  • [10] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
12345